A Comparison of the Blood Pressure Changes of Lumiracoxib With Those of Ibuprofen and Naproxen

The 52‐week Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET) investigated the gastrointestinal and cardiovascular safety profile of lumiracoxib 400 mg once daily compared with 2 traditional nonsteroidal anti‐inflammatory drugs (NSAIDs): ibuprofen 800 mg 3 times daily and napr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Hypertens (Greenwich)
Main Authors: Farkouh, Michael E., Verheugt, Freek W. A., Ruland, Sean, Kirshner, Howard, Jeger, Raban, Gitton, Xavier, Krammer, Gerhard, Stricker, Kirstin, Sallstig, Peter, Mellein, Bernhard, Matchaba, Patrice, Chesebro, James H.
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Publishing Inc 2008
Assuntos:
Original Papers
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8109916/
https://ncbi.nlm.nih.gov/pubmed/18772641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1751-7176.2008.07802.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares